Factors affecting procedural pain in children during and immediately after intramuscular botulinum toxin injections

M T Fisher1, C K Zigler2, A J Houtrow2

  • 1Division of Pediatric Rehabilitation Medicine, Children's Mercy Hospital, Kansas City, MO, USA.

Insights

Younger children experience more pain during botulinum toxin A injections. Topical anesthetics and injection site influence pain, but most patients report mild or no pain post-procedure.

Area of Science:

  • Pediatric Pain Management
  • Neuromuscular Blockade Therapy

Background:

  • Intramuscular botulinum toxin A injections are common in pediatric care.
  • Understanding pain modulation is crucial for improving patient experience.

Purpose of the Study:

  • To identify variables influencing pain during intramuscular botulinum toxin A injections in children.
  • To inform Quality Improvement initiatives for pediatric injection procedures.

Main Methods:

  • Retrospective analysis of 593 procedures involving 249 unique pediatric patients.
  • Comparison of reported pain with patient and procedural variables using subgroup and regression analyses.

Main Results:

  • Mean procedural pain was 3.8 ± 3.0; 83.8% reported no pain and 12.1% mild pain five minutes post-injection.
  • Younger age, use of vapo-coolant spray or topical anesthetic, and body region injected were associated with increased procedural pain.
  • Pain during the procedure and older age increased the likelihood of post-procedure pain; distraction methods did not significantly predict pain ratings.

Conclusions:

  • Procedural pain is significantly influenced by patient age, topical anesthesia, and injected region.
  • The majority of children experience minimal pain within five minutes post-injection.
  • Findings suggest that frequent sedation or anesthesia may not be necessary for these procedures.
Abstract

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.2K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.7K
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.4K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
302
Factors Affecting Solubility04:01

Factors Affecting Solubility

Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
37.2K